دورية أكاديمية
أعرض في EDS

Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network.

التفاصيل البيبلوغرافية
العنوان: Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network.
المؤلفون: Kaluarachchi DC; Department of Pediatrics, University of Wisconsin-Madison, Madison, WI. Electronic address: kaluarachchi@pediatrics.wisc.edu., Rysavy MA; Department of Pediatrics, McGovern Medical School, UTHealth Houston, Houston, TX., Carper BA; Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, NC., Chock VY; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA., Laughon MM; Department of Pediatrics, University of North Carolina, Chapel Hill, NC., Backes CH; Department of Pediatrics, Ohio State University and Nationwide Children's Hospital, Columbus, OH., Colaizy TT; Department of Pediatrics, University of Iowa, Iowa City, IA., Bell EF; Department of Pediatrics, University of Iowa, Iowa City, IA., McNamara PJ; Department of Pediatrics, University of Iowa, Iowa City, IA.
المصدر: The Journal of pediatrics [J Pediatr] 2024 Mar; Vol. 266, pp. 113877. Date of Electronic Publication: 2023 Dec 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0375410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6833 (Electronic) Linking ISSN: 00223476 NLM ISO Abbreviation: J Pediatr Subsets: MEDLINE
أسماء مطبوعة: Original Publication: St. Louis, MO : Mosby
مواضيع طبية MeSH: Ductus Arteriosus, Patent*/surgery, Infant, Newborn ; Infant ; United States ; Child ; Humans ; Infant, Premature ; Ibuprofen/therapeutic use ; National Institute of Child Health and Human Development (U.S.) ; Indomethacin/therapeutic use
مستخلص: We evaluated changes in patent ductus arteriosus (PDA) diagnosis and treatment from 2012 through 2021 in a network of US academic hospitals. PDA treatment decreased among infants born at 26-28 weeks but not among infants born at 22-25 weeks. Rates of indomethacin use and PDA ligation decreased while acetaminophen use and transcatheter PDA closure increased.
Competing Interests: Declaration of Competing Interest D.C.K. serves as a consultant for ONY Biotech Inc. C.H.B. has following disclosures; Abbott Laboratories: funding of ongoing multicenter trial, in partnership with National Institutes of Health, entitled PIVOTAL (NCT05547165). Abbott Laboratories has no part in the design or execution of PIVOTAL. P.J.M. serves as a consultant for Abbot Laboratories and Aspect Ltd. The other authors declare no conflicts of interest.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
References: Pediatrics. 2017 Aug;140(2):. (PMID: 28701390)
J Pediatr. 2017 Oct;189:105-112. (PMID: 28600155)
Children (Basel). 2021 Jan 15;8(1):. (PMID: 33467401)
JAMA Pediatr. 2020 Aug 1;174(8):755-763. (PMID: 32539121)
Clin Perinatol. 2020 Sep;47(3):617-639. (PMID: 32713454)
JAMA. 2018 Mar 27;319(12):1221-1238. (PMID: 29584842)
Eur J Pediatr. 2021 Dec;180(12):3565-3575. (PMID: 34125292)
Pediatrics. 2020 Nov;146(5):. (PMID: 33093140)
J Perinatol. 2021 Jan;41(1):100-108. (PMID: 32792636)
Am J Respir Crit Care Med. 2023 Aug 1;208(3):290-300. (PMID: 37209133)
J Pediatr. 2018 Dec;203:225-233.e1. (PMID: 30243544)
Pediatrics. 2021 Nov;148(5):. (PMID: 34675131)
JAMA. 2022 Jan 18;327(3):248-263. (PMID: 35040888)
J Pediatr. 2019 Feb;205:41-48.e6. (PMID: 30340932)
J Pediatr. 2021 Feb;229:127-133. (PMID: 33069668)
Semin Perinatol. 2023 Mar;47(2):151721. (PMID: 36882362)
Pediatrics. 2017 Apr;139(4):. (PMID: 28562302)
J Pediatr. 2019 Oct;213:218-221. (PMID: 31255391)
J Perinatol. 2010 Apr;30(4):241-52. (PMID: 20182439)
J Pediatr. 2021 Jun;233:33-42.e2. (PMID: 33307111)
J Pediatr. 2021 Aug;235:49-57.e2. (PMID: 33864797)
Pediatr Res. 2016 Dec;80(6):785-792. (PMID: 27509008)
J Pediatr. 2019 Oct;213:222-226.e2. (PMID: 31255386)
J Pediatr. 2021 Mar;230:84-92.e14. (PMID: 33098843)
J Perinatol. 2019 Nov;39(11):1435-1436. (PMID: 31515503)
J Perinatol. 2023 Oct;43(10):1230-1237. (PMID: 37169914)
N Engl J Med. 2023 Mar 16;388(11):980-990. (PMID: 36477458)
J Pediatr. 2021 Aug;235:58-62. (PMID: 33894266)
معلومات مُعتمدة: UG1 HD068263 United States HD NICHD NIH HHS; UG1 HD087226 United States HD NICHD NIH HHS; U01 HD036790 United States HD NICHD NIH HHS; UG1 HD068270 United States HD NICHD NIH HHS; UG1 HD027856 United States HD NICHD NIH HHS; UG1 HD034216 United States HD NICHD NIH HHS; UL1 TR000454 United States TR NCATS NIH HHS; UG1 HD027904 United States HD NICHD NIH HHS; UL1 TR001117 United States TR NCATS NIH HHS; UG1 HD053109 United States HD NICHD NIH HHS; UG1 HD027851 United States HD NICHD NIH HHS; UG1 HD068278 United States HD NICHD NIH HHS; UG1 HD068244 United States HD NICHD NIH HHS; UG1 HD027853 United States HD NICHD NIH HHS; UL1 TR000042 United States TR NCATS NIH HHS; UG1 HD087229 United States HD NICHD NIH HHS; UG1 HD040689 United States HD NICHD NIH HHS; UL1 TR001449 United States TR NCATS NIH HHS; UG1 HD053089 United States HD NICHD NIH HHS; UL1 TR000442 United States TR NCATS NIH HHS; UL1 TR001108 United States TR NCATS NIH HHS; UL1 TR001085 United States TR NCATS NIH HHS; UG1 HD068284 United States HD NICHD NIH HHS; UG1 HD021385 United States HD NICHD NIH HHS; UL1 TR001425 United States TR NCATS NIH HHS; UG1 HD040492 United States HD NICHD NIH HHS; UG1 HD021364 United States HD NICHD NIH HHS; UG1 HD027880 United States HD NICHD NIH HHS; UL1 TR000105 United States TR NCATS NIH HHS
فهرسة مساهمة: Keywords: patent ductus arteriosus; preterm infant; secular trends
المشرفين على المادة: WK2XYI10QM (Ibuprofen)
XXE1CET956 (Indomethacin)
تواريخ الأحداث: Date Created: 20231222 Date Completed: 20240226 Latest Revision: 20240309
رمز التحديث: 20240309
مُعرف محوري في PubMed: PMC10922632
DOI: 10.1016/j.jpeds.2023.113877
PMID: 38135028
قاعدة البيانات: MEDLINE
الوصف
تدمد:1097-6833
DOI:10.1016/j.jpeds.2023.113877